Weight-loss power of oats naturally mimics popular obesity drugs
A University of Arizona study found that beta-glucan, a fiber in oats, may mimic obesity medications' weight-loss effects, improving metabolic health and gut microbiota in mice on high-fat diets.
Read original articleA recent study led by researchers at the University of Arizona has found that beta-glucan, a type of fiber abundant in oats, may mimic the weight-loss effects of popular obesity medications like Ozempic. The study focused on how different fibers affect gut microbiota and metabolic health. Mice fed a high-fat, high-sucrose diet supplemented with 10% beta-glucan showed significantly lower weight gain and fat mass, along with higher lean mass compared to those on other fiber diets. These mice also exhibited improved insulin sensitivity and better blood glucose levels over the 18-week study period. The beneficial effects were linked to changes in gut bacteria and the production of metabolites, particularly butyrate, which is known to stimulate the release of appetite-regulating hormones like GLP-1. This suggests that dietary fiber, specifically beta-glucan, can enhance metabolic health and aid in weight management without the side effects associated with pharmaceutical options. The findings highlight the potential of oats and similar foods in combating obesity and improving overall health. The researchers aim to develop enhanced fibers that could further boost butyrate production during digestion. The study was published in The Journal of Nutrition.
Related
'Skinny jabs': weight-loss drugs set for new boom as generic versions emerge
Medicines like Wegovy and Saxenda, known as "skinny jabs," are gaining popularity for weight loss. Generic versions, like Teva's generic Victoza, are expected to increase accessibility and affordability, benefiting a broader population. Novo Nordisk invests $4 billion to meet rising demand.
Rare form of eye stroke that causes blindness now linked to Ozempic and Wegovy
A study links Ozempic and Wegovy to increased risk of rare blindness (NAION) in diabetes and obesity patients. While causation isn't confirmed, caution and consultation with healthcare providers are advised. Novo Nordisk prioritizes patient safety.
GLP-1 Drugs Like Wegovy, Ozempic Potentially Linked to Blinding Disease
A study suggests a potential link between GLP-1 drugs like semaglutide and a rare blinding disease called NAION in patients with diabetes or obesity. Further research is needed to clarify this association.
Natural olive compound aids weight loss and regulates blood sugar
Researchers at Virginia Tech found elenolic acid in olives aids weight loss and blood sugar control. Derived from oleuropein in olive oil, it shows promise in treating obesity and diabetes naturally.
Not Everyone Loses Weight on Ozempic
Some patients may not achieve significant weight loss with GLP-1 drugs like Ozempic and Wegovy, despite promising trial results. Factors like genetics and adherence influence responses. Newer drugs like tirzepatide aim to improve effectiveness.
Related
'Skinny jabs': weight-loss drugs set for new boom as generic versions emerge
Medicines like Wegovy and Saxenda, known as "skinny jabs," are gaining popularity for weight loss. Generic versions, like Teva's generic Victoza, are expected to increase accessibility and affordability, benefiting a broader population. Novo Nordisk invests $4 billion to meet rising demand.
Rare form of eye stroke that causes blindness now linked to Ozempic and Wegovy
A study links Ozempic and Wegovy to increased risk of rare blindness (NAION) in diabetes and obesity patients. While causation isn't confirmed, caution and consultation with healthcare providers are advised. Novo Nordisk prioritizes patient safety.
GLP-1 Drugs Like Wegovy, Ozempic Potentially Linked to Blinding Disease
A study suggests a potential link between GLP-1 drugs like semaglutide and a rare blinding disease called NAION in patients with diabetes or obesity. Further research is needed to clarify this association.
Natural olive compound aids weight loss and regulates blood sugar
Researchers at Virginia Tech found elenolic acid in olives aids weight loss and blood sugar control. Derived from oleuropein in olive oil, it shows promise in treating obesity and diabetes naturally.
Not Everyone Loses Weight on Ozempic
Some patients may not achieve significant weight loss with GLP-1 drugs like Ozempic and Wegovy, despite promising trial results. Factors like genetics and adherence influence responses. Newer drugs like tirzepatide aim to improve effectiveness.